Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Berkman

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Allergy|January 6, 2009
The role of eosinophil major basic protein in angiogenesisI Puxeddu, N Berkman, A H Nissim Ben Efraim, et al.
Immunology|April 1, 1996
Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13N Berkman, A Robichaud, V L Krishnan, et al.
Respiration; International Review of Thoracic Diseases|October 12, 1999
Effect of immunomodulators on bleomycin-induced lung injuryS Kremer, R Breuer, I S Lossos, et al.
Allergy|October 7, 2009
Osteopontin is expressed and functional in human eosinophilsI Puxeddu, N Berkman, D Ribatti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 30, 2015
Cluster of Fusarium solani isolations in a Bronchoscopy UnitL Levy, C Block, C Schwartz, et al.
Allergy|February 1, 2005
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthmaJ Bousquet, P Cabrera, N Berkman, et al.
Biochemical and Biophysical Research Communications|November 30, 1994
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungsP J Jose, I M Adcock, D A Griffiths-Johnson, et al.
Circulation|April 1, 1993
Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemiaE Leitersdorf, S Eisenberg, O Eliav, et al.
Biopharmaceutics & Drug Disposition|January 1, 1994
Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatmentM Bialer, S Hadad, G Golomb, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemiaE Leitersdorf, S Eisenberg, O Eliav, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Allergy|January 6, 2009
The role of eosinophil major basic protein in angiogenesisI Puxeddu, N Berkman, A H Nissim Ben Efraim, et al.
Immunology|April 1, 1996
Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13N Berkman, A Robichaud, V L Krishnan, et al.
Respiration; International Review of Thoracic Diseases|October 12, 1999
Effect of immunomodulators on bleomycin-induced lung injuryS Kremer, R Breuer, I S Lossos, et al.
Allergy|October 7, 2009
Osteopontin is expressed and functional in human eosinophilsI Puxeddu, N Berkman, D Ribatti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 30, 2015
Cluster of Fusarium solani isolations in a Bronchoscopy UnitL Levy, C Block, C Schwartz, et al.
Allergy|February 1, 2005
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthmaJ Bousquet, P Cabrera, N Berkman, et al.
Biochemical and Biophysical Research Communications|November 30, 1994
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungsP J Jose, I M Adcock, D A Griffiths-Johnson, et al.
Circulation|April 1, 1993
Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemiaE Leitersdorf, S Eisenberg, O Eliav, et al.
Biopharmaceutics & Drug Disposition|January 1, 1994
Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatmentM Bialer, S Hadad, G Golomb, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemiaE Leitersdorf, S Eisenberg, O Eliav, et al.
Pageof 9